Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Bayer AG BAYRY OTC

Other OTC • Healthcare • Drug Manufacturers - General • DE • USD

SharesGrow Score
33/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Bayer AG (BAYRY) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 1 Buy, 2 Hold.

BAYRY Analyst Ratings

Hold
3
Ratings
1 Buy
2 Hold
Based on 3 analysts giving stock ratings to Bayer AG in the past 3 months
Rating breakdown
Buy
1 33%
Hold
2 67%
33%
Buy
1 analysts
67%
Hold
2 analysts
0%
Sell
0 analysts

People Also View

RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
 NVS
NVS
Novartis AG
$153.38
-0.71%
 GILD
GILD
Gilead Sciences, Inc.
$140.45
+1.02%
 GSK
GSK
GSK plc
$59.18
+0.41%
 BMY
BMY
Bristol-Myers Squibb Company
$58.08
+0.03%
 SNY
SNY
Sanofi
$47.64
+1.45%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message